Results

Total Results: 1,149 records

Showing results for "drugs".

161. Weingart SN et al. 2003 "Physicians' decisions to override computerized drug alerts in primary care." | Digital Healthcare Research
     digital.ahrq.gov/health-it-tools-and-resources/workflow-assessment-health-it-toolkit/research/weingart-sn-et-al-2003
     January 01, 2003 - Weingart SN et al. 2003 "Physicians' decisions to override computerized drug alerts in primary care." Reference Weingart SN, Toth M, Sands DZ, et al. Physicians' decisions to override computerized drug alerts in primary care. Arch Intern Med 2003;163(21):2625-2631. [Link] Abstract "Backgroun…

162. A Demonstration Project: Assessing the Significance and Impact of Utilizing a Novel Telemedicine Application in the Delivery of Community-Based Palliative Care in a Rural Seriously Ill Population | Digital Healthcare Research
     digital.ahrq.gov/ahrq-funded-projects/demonstration-project-assessing-significance-and-impact-utilizing-novel
     January 01, 2023 - illness, the natural aging process, and multiple-drug treatment—affect their ability to metabolize drugs

163. Safety Through Enhanced e-PreScribing Tools (STEPStools): Developing Web Services for Safe Pediatric Dosing - 2010 | Digital Healthcare Research
     digital.ahrq.gov/ahrq-funded-projects/safety-through-enhanced-e-prescribing-tools-stepstools-developing-web-services/annual-summary/2010
     January 01, 2010 - Library of Medicine and RxNorm, the drug nomenclature for standardizing the representation of clinical drugs

164. Prescription Drug Monitoring Program Integration in the Electronic Health Record | Digital Healthcare Research
     digital.ahrq.gov/ahrq-funded-projects/prescription-drug-monitoring-program-integration-electronic-health-record
     March 31, 2024 - Prescription Drug Monitoring Program Integration in the Electronic Health Record Project Final Report ( PDF , 415.31 KB) Disclaimer Disclaimer The findings and conclusions in this document are those of the author(s), who are responsible for its content, and do not necessarily rep…

165. Artificial Intelligence-Based Health Information Technology Tools to Optimize Critical Care Pharmacist Resources Through Adverse Drug Event Prediction | Digital Healthcare Research
     digital.ahrq.gov/ahrq-funded-projects/artificial-intelligence-based-health-it-tools-optimize-critical-care
     January 01, 2025 - Artificial Intelligence-Based Health Information Technology Tools to Optimize Critical Care Pharmacist Resources Through Adverse Drug Event Prediction Project Description Publications Research Story Developing artificial intelligence-based health information technol…

166. R18Hs017216-Johnson-Final-Report-2011 (pdf file)
     digital.ahrq.gov/sites/default/files/docs/publication/r18hs017216-johnson-final-report-2011.pdf
     January 01, 2011 - Narrow Therapeutic Range The third approach recognized the potential for drugs to have a narrow therapeutic … Drugs such as digoxin and insulin are in this category, and typically are not rounded, or are rounded … In most cases, these drugs can be safely rounded to the nearest 10th of a milliliter, or, in neonates … These drugs included anti-retroviral medications (ritonavir, oseltamivir, lamivudine) and some rarely … asked interviewees to demonstrate their use of the e- prescribing system when prescribing some of the drugs

167. Pain Management Resources to Support Clinical Decision Support Artifact Development: An Environmental Scan (pdf file)
     digital.ahrq.gov/sites/default/files/docs/citation/cds-connect-environmental-scan.pdf
     December 01, 2017 - heroin epidemic [18], since opioids (primarily prescription pain relievers and heroin) are the main drugs … “Adjuvant analgesic drugs” often used for other conditions can also be considered (e.g., anticonvulsants … Whether active OUD began with prescription drugs or illicit drugs, evidence increasingly shows that … focus on several areas: • Provider selection of and management of MAT therapy, using the various drugs … available 20 • Education for patients and family caregivers about MAT drugs and their effects

168. Magnus D et al. 2002 "GPs' views on computerized drug interaction alerts: questionnaire survey." | Digital Healthcare Research
     digital.ahrq.gov/health-it-tools-and-resources/workflow-assessment-health-it-toolkit/research/magnus-d-et-al-2002-gps
     January 01, 2002 - Magnus D et al. 2002 "GPs' views on computerized drug interaction alerts: questionnaire survey." Reference Magnus D, Rodgers S, Avery AJ. GPs' views on computerized drug interaction alerts: questionnaire survey. J Clin Pharm Ther 2002;27(5):377-382. Abstract "Background: There is evidence that…

169. Automated Adverse Drug Event Detection and Intervention - Final Report (pdf file)
     digital.ahrq.gov/sites/default/files/docs/publication/uc1hs014882-ferranti-final-report-2008.pdf
     January 01, 2008 - We assessed the primary drugs that generated ADEs in this specialized patient population, as well as

170. Discovery and Visualization of New Information from Clinical Reports in the EHR - Final Report (pdf file)
     digital.ahrq.gov/sites/default/files/docs/citation/r01hs022085-melton-meaux-final-report-2018.pdf
     January 01, 2018 - identifying drug-drug interactions in outpatient notes, we found 14 unknown pairs of interacting drugs … breast cancer patients’ susceptibility to cardiotoxicity caused by five first-line antineoplastic drugs … Mining Biomedical Literature to Explore Interactions between Cancer Drugs and Dietary Supplements. … Exploiting Literature-derived Knowledge and Semantics to Identify Potential Prostate Cancer Drugs. … Mining Biomedical Literature to Explore Interactions between Cancer Drugs and Dietary Supplements.

171. National Web-Based Teleconference on Utilizing Health IT to Improve Medication Management for the Care of Elderly Patients (pdf file)
     digital.ahrq.gov/sites/default/files/docs/medication-management-elderly-slides-081811.pdf
     August 18, 2011 - Drug-drug interactions: – interaction alerts were beneficial to patient safety – Highly regarded for drugs

172. AHRQ National Webinar on Medication Without Harm – How Digital Healthcare Tools Can Support Providers and Improve Patient Safety - Q&As (pdf file)
     digital.ahrq.gov/sites/default/files/docs/medication-without-harm-qas-07242024.pdf
     July 24, 2024 - These users look at the order set and internalize what drugs are being recommended and frequency, and … then they order those drugs through their own ordering process that has been ironed out for their

173. Enhancing Medication CPOE Safety and Quality by Indications-Based Prescribing | Digital Healthcare Research
     digital.ahrq.gov/ahrq-funded-projects/enhancing-medication-cpoe-safety-and-quality-indications-based-prescribing
     January 01, 2023 - The prototype gave prescribers a way to record the indication, and it showed them the drug or drugs of

174. Preventing Wrong-Drug and Wrong-Patient Errors With Indication Alerts in CPOE Systems | Digital Healthcare Research
     digital.ahrq.gov/ahrq-funded-projects/preventing-wrong-drug-and-wrong-patient-errors-indication-alerts-cpoe-systems
     January 01, 2023 - Preventing Wrong-Drug and Wrong-Patient Errors With Indication Alerts in CPOE Systems Project Final Report ( PDF , 953.21 KB) Disclaimer Disclaimer The findings and conclusions in this document are those of the author(s), who are responsible for its content, and do not necessaril…

175. Drug-drug interaction between dexamethasone and direct-acting oral anticoagulants: A nested case-control study in the national COVID cohort collaborative (N3C). | Digital Healthcare Research
     digital.ahrq.gov/ahrq-funded-projects/meaningful-drug-interaction-alerts/citation/drug
     January 01, 2023 - Drug-drug interaction between dexamethasone and direct-acting oral anticoagulants: A nested case-control study in the national COVID cohort collaborative (N3C). Citation Kravchenko OV, Boyce RD, Gomez-Lumbreras A, Kocis PT, Villa Zapata L, Tan M, Leonard CE, Andersen KM, Mehta H, Alexander GC, Malone …

176. Coordinated use of Health Level 7 standards to support clinical decision support: Case study with shared decision making and drug-drug interactions. | Digital Healthcare Research
     digital.ahrq.gov/ahrq-funded-projects/enabling-shared-decision-making-reduce-harm-drug-interactions-end-end/citation/coordinated
     January 01, 2023 - Coordinated use of Health Level 7 standards to support clinical decision support: Case study with shared decision making and drug-drug interactions. Citation Thiess H, Del Fiol G, Malone DC, Cornia R, Sibilla M, Rhodes B, Boyce RD, Kawamoto K, Reese T. Coordinated use of Health Level 7 standards to su…

177. Ferranti, Jeffrey | Digital Healthcare Research
     digital.ahrq.gov/principal-investigator/ferranti-jeffrey
     January 01, 2023 - Ferranti, Jeffrey Sharing adverse drug event data using business intelligence technology. Citation Horvath MM, Cozart H, Ahmad A, et al. Sharing adverse drug event data using business intelligence technology. J Patient Saf 2009 Mar;5(1):35-41. Principal Investigator …

178. Evaluation of Effectiveness of a Health Information Technology-Based Care Transition Information Transfer System - 2012 | Digital Healthcare Research
     digital.ahrq.gov/ahrq-funded-projects/evaluation-effectiveness-health-information-technology-based-care-transition/annual-summary/2012
     January 01, 2012 - time that each list was completed and when the call with the patient took place, whether short-term drugs

179. Bailey, Thomas | Digital Healthcare Research
     digital.ahrq.gov/principal-investigator/bailey-thomas
     January 01, 2023 - Bailey, Thomas Natural language processing to identify adverse drug events. Citation Gysbers M, Reichley R, Kilbridge PM, et al. Natural language processing to identify adverse drug events. AMIA Annu Symp Proc 2008 Nov 6:961. Principal Investigator Bailey, Thomas …

180. Layout 1 (pdf file)
     digital.ahrq.gov/sites/default/files/docs/page/08-0093_cpoe.pdf
     August 01, 2008 - correctly, can automatically check for many such potential errors, helping to avoid potentially hazardous drugs